Important Safety Information WARNING: RISK OF THYROID C-CELL TUMORS Liraglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice
Systematic IUPAC Name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid Purity & Quality Our PT-141 is provided at research-grade purity, suitable for laboratory applications and experimental protocols
"These knock-offs are synthesized in non-medical environments without the necessary quality assurance or quality control, making them inherently risky." There is the potential for these medications to be harmful when theres no oversight of their source or production quality, Osborn warned
Heres a breakdown to help you understand what to expect